European Registry on Obstetrical Anti-Phospholipid Antibody Syndrome (EUROAPS)

and

Obstetric Morbidity Related to aPL (EUROMAP)

This project is included in the frame of European Forum of Antiphospholipid projects.

Coordinator: Jaume Alijotas-Reig

International Advisory  Committee

Ricard Cervera

Munter Khamashta

Amelia Ruffatti

Angela Tincani

Emeritus

Marie- Claire Boffa

Antiphospholipid antibodies (aPL) are a family of autoantibodies that joined to negatively charged phospholipids, protein-binding phospholipids or both (1). The antiphospholipid syndrome (APS) is characterized by an increased risk of vascular thrombosis involving venous, arterial and placental circulation. To meet APS diagnosis, clinical and laboratory Sydney criteria have to be fulfilled (2).